[1]
K. Andrade Vera, L. Fischman, G. Bambés, S. Bartolomeo, and L. Carreras Vescio, “Immunohematological finding anticipates refractoriness to treatment with daratumumab in a patient with multiple mieloma”, RH, vol. 22, no. 2, pp. 185–187, Jan. 2019.